News | Artificial Intelligence | August 09, 2023

Annalise.ai’s solutions are now available for clinical use in more than 40 countries with the latest clearances from the EU and Singapore

Annalise.ai’s solutions are now available for clinical use in more than 40 countries with the latest clearances from the EU and Singapore.

August 9, 2023 — Annalise.ai, one of the global leaders of AI decision-support solutions, announced that their Annalise Enterprise CTB for interpreting non-contrast head CT studies has received multiple additional regulatory approvals. Annalise Enterprise CTB is now CE marked as class IIb under EU Medical Device Regulation (EU MDR) and additionally has been approved for clinical use in Singapore. 

The EU MDR and Singapore regulatory approvals signify a remarkable milestone for Annalise.ai, reaffirming the company's dedication to meeting the highest standards of safety and effectiveness. These certifications extend to the chest X-ray solution Annalise Enterprise CXR, highlighting the company's commitment to delivering cutting-edge AI technology to global healthcare markets through its comprehensive Enterprise AI platform. 

"These regulatory approvals demonstrate our commitment to delivering top-quality, compliant, and innovative AI solutions to our valued customers and prospects. We are excited to enter the EU and Singapore markets. This is a significant step forward in our mission to improve patient outcomes globally through AI-driven healthcare," said Lakshmi Gudapakkam, CEO of Annalise.ai. 

Annalise Enterprise CTB detects up to 130 radiological findings on non-contrast CT Brain (NCCTB) studies, including a wide range of conditions that require rapid intervention. It has been shown to improve diagnostic accuracy by 32%, averaged across all analyzed findings. Annalise Enterprise CXR can detect up to 124 findings on chest X-rays in under 20 seconds. It has been shown to improve accuracy by 45%, averaged across all analyzed findings2. The solutions allow worklist prioritization which supports reporting workflow efficiency by marking critical or unremarkable cases, according to clinical needs. 

The latest round of regulatory approvals adds to a growing list for Annalise.ai, which has rapidly expanded its global footprint since its inception in 2020. Annalise Enterprise solutions are used in public and private healthcare in Australia, the United Kingdom, the United States, and throughout South East Asia. More approvals are anticipated as the company continues pursuing its mission to raise the standard of healthcare for millions of patients with cutting-edge, clinician-friendly AI technology. 

For more information: www.annalise.ai 

Related content: 

Austrailian Healthtech Leader Analise.ai Releases Next-Generation CT Brain AI Solution for Clinical Use 

Breakthrough Radiology AI Provider annalise.ai Appoints Proven Global Healthcare Leader as CEO, Officially Launches US team Following FDA Clearances 


Related Content

News | Enterprise Imaging

June 20, 2024 — Agfa announces its participation in the upcoming Society for Imaging Informatics in Medicine (SIIM) 2024 ...

Time June 20, 2024
arrow
News | SIIM

June 20, 2024 — The Society for Imaging Informatics in Medicine (SIIM) is gearing up for its SIIM24 Annual Meeting and ...

Time June 20, 2024
arrow
News | Cybersecurity

June 19, 2024 —Karamba Security, a world leader in end-to-end product security, today announced the signing of a ...

Time June 19, 2024
arrow
News | Mobile C-Arms

June 19, 2024 —Royal Philips, a global leader in health technology, today announced the launch of Philips Image Guided ...

Time June 19, 2024
arrow
News | Artificial Intelligence

June 18, 2024 — The advancement of Artificial Intelligence (AI) in healthcare to support diagnostic decision making ...

Time June 18, 2024
arrow
News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 18, 2024
arrow
News | Lung Imaging

June 18, 2024 — A new study led by American Cancer Society (ACS) researchers shows less than one-in-five eligible ...

Time June 18, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

June 17, 2024 — MRI has transformed neuroscience research over the past 50 years, but research participants have had to ...

Time June 17, 2024
arrow
News | Radiology Business

June 17, 2024 — Strategic Radiology welcomed Northwest Radiologists, Inc, a 20-radiologist practice based in Bellingham ...

Time June 17, 2024
arrow
Feature | Imaging Technology News - ITN

Dear Friends and Readers of ITN, Can you spare 3 minutes today to give us some feedback? Please share your insight with ...

Time June 17, 2024
arrow
Subscribe Now